Medpace Holdings, Inc. — Director's Dealing 2021

Dec 9, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Medpace Holdings, Inc. (MEDP)
CIK: 0001668397
Period of Report: 2021-12-07

Reporting Person: Medpace Investors, LLC (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-12-07	Common Stock	S	18520	$211.78	Disposed	5789404	Direct
2021-12-08	Common Stock	S	15871	$212.89	Disposed	5773533	Direct

Footnotes

F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 1, 2021.

F2: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $210.00 to $213.80. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.

F3: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $210.00 to $214.46. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.